摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-2-neopentyloxybenzonitrile | 206885-36-1

中文名称
——
中文别名
——
英文名称
5-amino-2-neopentyloxybenzonitrile
英文别名
5-amino-2-(2,2-dimethylpropoxy)benzonitrile
5-amino-2-neopentyloxybenzonitrile化学式
CAS
206885-36-1
化学式
C12H16N2O
mdl
——
分子量
204.272
InChiKey
DEINXCIUINFITP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    369.8±22.0 °C(Predicted)
  • 密度:
    1.06±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    59
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-amino-2-neopentyloxybenzonitrile 在 sodium hydride 、 三乙胺 作用下, 以 四氢呋喃 、 DMF (N,N-dimethyl-formamide) 为溶剂, 反应 6.5h, 生成 2-[N-tert-butoxycarbonyl-N-(3-cyano-4-neopentyloxyphenyl)]aminoethyl acetate
    参考文献:
    名称:
    AMIDE COMPOUNDS AND MEDICINAL USE THEREOF
    摘要:
    公开号:
    EP1176140B1
  • 作为产物:
    描述:
    2-氯-5-硝基苯甲腈铁粉 、 sodium hydride 、 氯化铵 作用下, 以 DMF (N,N-dimethyl-formamide) 、 乙醇 为溶剂, 反应 1.83h, 生成 5-amino-2-neopentyloxybenzonitrile
    参考文献:
    名称:
    AMIDE COMPOUNDS AND MEDICINAL USE THEREOF
    摘要:
    公开号:
    EP1176140B1
点击查看最新优质反应信息

文献信息

  • Fused bicyclic amide compounds and medicinal use thereof
    申请人:——
    公开号:US20030203909A1
    公开(公告)日:2003-10-30
    The present invention provides a compound represented by the formula (I) 1 wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R 1 , R 2 and R 3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X′ is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
    本发明提供了一种由以下化学式(I)1所代表的化合物,其中环A为苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等,环B为苯、环己烷、吡咯或其衍生物、呋喃、噻吩等,R1、R2和R3分别为氢、烷基、卤素、羟基、烷氧基等,W为氢、烷基或羟基羰基烷基,X为卤素、氰基、硝基等,X′为氢、卤素等,Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等,其盐和含有该化合物的药物。本发明的化合物对活化淋巴细胞的增殖具有优越的抑制作用,并可用作各种自身免疫性疾病的预防或治疗剂。
  • Amide compounds and medicinal use thereof
    申请人:Mitsubishi Pharma Corporation
    公开号:US07015218B1
    公开(公告)日:2006-03-21
    The present invention relates to a compound of the formula wherein R1 is substituted aryl, heteroaryl and the like, R2 and R3 are hydrogen, alkyl, halogen, hydroxyl group and the like, Q is N, CH and the like, W is hydrogen, alkyl, hydroxycarbonylalkyl and the like, X is halogen, cyano, nitro, amino and the like, X′ is hydrogen, halogen, cyano, nitro, and Y is alkyl, hydroxyl group, alkoxy, mercapto and the like and a salt thereof, and a medicine containing the said compound. The compound of the present invention shows a superior inhibitory effect on activated lymphocytes proliferation and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
    本发明涉及一种化合物,其化学式为其中R1为取代芳基,杂环芳基等,R2和R3为氢,烷基,卤素,羟基等,Q为N,CH等,W为氢,烷基,羟基羧基烷基等,X为卤素,氰基,硝基,氨基等,X'为氢,卤素,氰基,硝基,Y为烷基,羟基,烷氧基,巯基等及其盐,以及包含所述化合物的药物。本发明的化合物显示出对活化淋巴细胞增殖的优越抑制作用,并可用作各种自身免疫性疾病的预防或治疗剂。
  • FUSED BICYCLIC AMIDE COMPOUNDS AND MEDICINAL USE THEREOF
    申请人:Mitsubishi Pharma Corporation
    公开号:EP1310488A1
    公开(公告)日:2003-05-14
    The present invention provides a compound represented by the formula (I) wherein ring A is benzene, cyclohexane, pyridine, piperidine or a derivative thereof, imidazole or a derivative thereof and the like, ring B is benzene, cyclohexane, pyrrole or a derivative thereof, furan, thiophene and the like, R1, R2 and R3 are each hydrogen, alkyl, halogen, hydroxyl group, alkoxy and the like, W is hydrogen, alkyl or hydroxycarbonylalkyl, X is halogen, cyano, nitro and the like, X' is hydrogen, halogen and the like, and Y is alkyl, hydroxyalkyl, hydroxycarbonylalkyl, aminoalkyl and the like, a salt thereof, and a pharmaceutical agent containing the compound. The compound of the present invention shows a superior inhibitory effect on the proliferation of activated lymphocyte and is useful as an agent for the prophylaxis or treatment of various autoimmune diseases.
    本发明提供了一种由式(I)表示的化合物 其中环 A 是苯、环己烷、吡啶、哌啶或其衍生物、咪唑或其衍生物等,环 B 是苯、环己烷、吡咯或其衍生物、呋喃、噻吩等,R1、R2 和 R3 分别是氢、烷基、卤素、羟基、烷氧基等,W 是氢、烷基或羟基羰基烷基,X 是卤素、氰基、硝基等、W为氢、烷基或羟基羰基烷基,X为卤素、氰基、硝基等,X'为氢、卤素等,Y为烷基、羟基烷基、羟基羰基烷基、氨基烷基等,其盐以及含有该化合物的药剂。本发明的化合物对活化淋巴细胞的增殖有很好的抑制作用,可作为预防或治疗各种自身免疫性疾病的药物。
  • US7015218B1
    申请人:——
    公开号:US7015218B1
    公开(公告)日:2006-03-21
  • US7112594B2
    申请人:——
    公开号:US7112594B2
    公开(公告)日:2006-09-26
查看更多